Olema Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-13. The offering totals $87.4M, of which $87.4M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 37 people.
| Name | Role | Location |
|---|---|---|
| Sean Bohen | Director | STEVENAGE, HERTFORDSHIRE, X0 |
| Cynthia Butitta | Director | Princeton, NJ |
| Ian Clark | Director | SOUTH SAN FRANCISCO, CA |
| Cyrus Harmon | Director | San Francisco, CA |
| Gorjan Hrustanovic | Director | San Diego, CA |
| Frank McCormick | Director | PALO ALTO, CA |
| Andrew Rappaport | Director | San Francisco, CA |
| Graham Walmsley | Director | San Francisco, CA |
| Sean Bohen | Executive Officer | STEVENAGE, HERTFORDSHIRE, X0 |
| Cyrus Harmon | Executive Officer | San Francisco, CA |
| Kinney Horn | Executive Officer | San Francisco, CA |
| Shane Kovacs | Executive Officer | San Francisco, CA |
| Peter Kushner | Executive Officer | San Francisco, CA |
| John Moriarty | Executive Officer | San Francisco, CA |
| David Myles | Executive Officer | Salt Lake City, UT |
| David C Myles, Ph.D. | Executive Officer | San Francisco, CA |
| Sandra L Horning, M.D. | Director | San Francisco, CA |
| Scott L Garland | Director | San Francisco, CA |
| Sean Bohen, M.D., Ph.D. | Director | San Francisco, CA |
| Sean Bohen, M.D., Ph.D. | Executive Officer | San Francisco, CA |
| Andrew C Rappaport | Director | San Francisco, CA |
| Graham L Walmsley, M.D., Ph.D. | Director | San Francisco, CA |
| Naseem C Zojwalla, M.D. | Executive Officer | San Francisco, CA |
| Yi C Larson | Director | San Francisco, CA |
| Cyrus L Harmon, Ph.D. | Director | San Francisco, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-12-12 | D | $250.0M | $250.0M |
| 2023-09-14 | D | $130.0M | $130.0M |
| 2020-06-23 | D/A | $55.4M | $53.9M |
| 2020-03-27 | D | $45.0M | $30.0M |
| 2018-08-27 | D | $6.1M | $6.1M |